Tag: USANA
USANA Reports Third Quarter 2025 Results
October 23, 2025
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 27, 2025. Key Financial Results Third Quarter 2025 vs. Third Quarter 2024 Net sales of $214 million versus $200 ...
Read more
USANA’s Vitamin D Earns Prestigious ConsumerLab Seal of Approval
October 17, 2025
USANA’s Vitamin D Supplement Shines Bright with ConsumerLab.com Seal of Approval, Setting the Standard for Product Quality USANA (NYSE:USNA), a global leader in cellular nutrition, is bringing a little more sunshine to wellness. Its top-rated Vitamin ...
Read more
Award-Winning Leadership: USANA’s Chief Scientific Officer Honored with Women Tech Award
October 7, 2025
Dr. Kathryn Armstrong, USANA chief scientific officer, named a “Leadership Excellence Award” winner USANA (NYSE:USNA) is proud to announce that its chief scientific officer, Dr. Kathryn Armstrong, has received the Women Tech Award from the Women ...
Read more
USANA Wins 2025 Good Housekeeping Beauty Award
May 1, 2025
USANA Celavive Postbiotic Rescue Serum Wins Good Housekeeping Beauty Award For 2025. USANA Health Sciences, Inc., (NYSE:USNA) a global leader in cellular nutrition, announced today that its Celavive Postbiotic Rescue Serum was named as a winner ...
Read more
USANA Q1 Revenue Up 10% To $250 Million
April 23, 2025
First Quarter 2025 vs. First Quarter 2024: Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency. “USANA is off to a solid start to the year as ...
Read more
USANA Appoints New Chief Scientific Officer
January 23, 2025
USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company. Kathryn has served as USANA’s executive ...
Read more
USANA Named Top Manufacturer
November 13, 2024
USANA Health Sciences, Inc. received the award for the Manufacturer of the Year by the Utah Manufacturers Association in the “mega-sized (500+ employees) companies” category. This is the third consecutive year that USANA has been recognized ...
Read more
USANA Q2 Revenue 11% Down To $213 Million
October 22, 2024
USANA Health Sciences, Inc.announced financial results for its fiscal second quarter ended June 29, 2024. Key Financial & Operating Results Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter diluted ...
Read more
USA Q2 Revenue 2024 Down 11% To $ 213 Million
July 24, 2024
USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended June 29, 2024. Key Financial & Operating Results Second quarter net sales were $213 million versus $238 million during Q2 2023. Second quarter diluted EPS was $0.54 as ...
Read more
USANA Executives Make First Visit To New India Market
July 23, 2024
CEO Jim Brown visits the country to meet the local team, leaders, and share long-term vision for the market. Reaching one million active customers is the first step towards USANA Health Sciences, Inc.’s mission of building ...
Read more
284 USANA-Sponsored Athletes In 2024 Summer Olympic Games In France
July 18, 2024
USANA Health Sciences, Inc. wishes the very best for the 284 sponsored USANA Athletes who earned their spot at the 2024 Summer Olympic and Paralympic Games in Paris. These athletes represent 10 nations including Canada, China, ...
Read more
USANA Q1 Revenue 2024 Down 8% To $228 Million
May 2, 2024
Key Financial & Operating Results First quarter net sales were $228 million versus $248 million during Q1 2023, and increased 2% sequentially in constant currency. First quarter diluted EPS was $0.86 as compared with $0.95 during ...
Read more